Raymond James Financial’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.9M Buy
474,800
+265,351
+127% +$8.36M ﹤0.01% 1684
2025
Q4
$6.17M Sell
209,449
-34,653
-14% -$963K ﹤0.01% 2343
2025
Q3
$6.16M Sell
244,102
-45,320
-16% -$1.1M ﹤0.01% 2320
2025
Q2
$6.95M Sell
289,422
-108,602
-27% -$2.52M ﹤0.01% 2149
2025
Q1
$9.11M Sell
398,024
-53,654
-12% -$1.29M ﹤0.01% 1877
2024
Q4
$11.4M Buy
+451,678
New +$11.4M ﹤0.01% 1739

Other funds holding RTO

Raymond James Financial's RTO Position: Q1 2026 in Review

Raymond James Financial increased its Rentokil (RTO) stake by 127% in Q1 2026, buying an estimated $8.36M and bringing the position to 474,800 shares worth $14.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1684.

Raymond James Financial first reported a position in RTO in Q4 2024 and has held it in 6 quarters since. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Raymond James Financial held 474,800 shares of Rentokil worth $14.9M as of Q1 2026.
  • Raymond James Financial bought 265,351 Rentokil shares in Q1 2026, an estimated $8.36M.
  • Rentokil made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #1684 holding.
  • Raymond James Financial first reported a position in Rentokil in Q4 2024 and has held it in 6 quarters since.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.